RVL Pharmaceuticals PLC (NASDAQ:RVLP)
| 0.0858 Delayed Data As of 3:58pm ET |  +0.0077 / +9.86%Today’s Change | 0.08 Today|||52-Week Range 2.42 | -92.34% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 218.5M | 245.7M | 263.7M | -- | |
| Cost of Goods Sold | 103.3M | 79.8M | 55.3M | -- | ||
| Depreciation And Amortization | 23.6M | 46.5M | 81.6M | -- | ||
| Operating Expenses | Gross Income | 91.6M | 119.5M | 126.8M | -- | |
| General Expenses | 90.6M | 98.0M | 121.2M | -- | ||
| Research And Development | 29.1M | 42.7M | 48.8M | -- | ||
| Total Operating Expenses | 217.4M | 224.2M | 258.0M | -- | ||
| Non-Operating Expenses | Operating Income | 1.0M | 21.5M | 5.7M | -- | |
| Extraordinary Charge | -33.1M | -73.6M | -104.2M | -- | ||
| Interest Expense On Debt | 20.2M | 29.1M | 20.8M | -- | ||
| Other Expenses | 168.7K | -4.5M | 664.4K | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -52.1M | -85.6M | -118.7M | -- | |
| Income Taxes | -10.2M | -40.5M | -9.3M | -- | ||
| Net Income | -41.8M | -45.2M | -109.4M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 52.5M | 52.5M | 45.3M | -- | |
| Shares To Calculate EPS Diluted | 52.5M | 52.5M | 45.3M | -- | ||
| Earnings Per Share | EPS | -$0.80 | -$0.86 | -$2.42 | -- | |
| EPS Diluted | -$0.80 | -$0.86 | -$2.42 | -- | ||
